Search

Your search keyword '"Rodon Ahnert, Jordi"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Rodon Ahnert, Jordi" Remove constraint Author: "Rodon Ahnert, Jordi" Publisher american society of clinical oncology Remove constraint Publisher: american society of clinical oncology
22 results on '"Rodon Ahnert, Jordi"'

Search Results

2. Phase 1/2 study of FOG-001, a first-in-class direct β-catenin:TCF inhibitor, in patients with colorectal cancer, hepatocellular carcinoma, and other locally advanced or metastatic solid tumors.

4. Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations.

6. Phase 2, multicenter, open-label basket trial of nab -sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).

8. A phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors.

12. Molecular landscape and survival outcomes on early phase clinical trials in sporadic young onset colorectal cancer.

13. Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results.

15. Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers.

16. Safety and efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid and CNS tumors: Results from a phase 1/2a study.

19. Baseline symptom, health status, and health utilities in patients in early-phase clinical trials combining immune checkpoint blockade with other anticancer therapies.

20. Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).

22. What It Takes to Improve a First-Generation Inhibitor to a Second- or Third-Generation Small Molecule.

Catalog

Books, media, physical & digital resources